valine has been researched along with Graft-Versus-Host Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatou, S; Imada, T; Ishida, S; Kawakami, Y; Kawakita, T; Miyashita, H; Mori, T; Nakamura, S; Ogawa, Y; Okamoto, S; Ozawa, Y; Satofuka, S; Shimmura, S; Tsubota, K; Yaguchi, S; Yaguchi, T; Yoshida, S | 1 |
| Arnost, MJ; Bennani, YL; Bethiel, RS; Black, JJ; Brummel, CL; Chakilam, A; Cochran, JE; Dorsch, WA; Fan, B; Farmer, LJ; Halas, S; Harrington, EM; Hogan, JK; Hoock, T; Howe, D; Huang, H; Jacobs, DH; Laitinen, LM; Ledeboer, MW; Liao, S; Mahajan, S; Marone, V; Martinez-Botella, G; McCarthy, P; Messersmith, D; Namchuk, M; Oh, L; Penney, MS; Pierce, AC; Raybuck, SA; Rugg, A; Salituro, FG; Saxena, K; Shannon, D; Shlyakter, D; Swenson, L; Tian, SK; Town, C; Wang, J; Wang, T; Wannamaker, MW; Winquist, RJ; Zuccola, HJ | 1 |
| Ariza-Heredia, EJ; Foo, WC; Gutierrez, C; Kebriaei, P; Turner, KA; Yemelyanova, A | 1 |
| Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J | 1 |
| Geusau, A; Greinix, H; Rabitsch, W; Stary, G; Stingl, G; Vormittag, L | 1 |
| Au, WY; Fung, A; Kwong, YL; Lam, CC; Lam, KY; Lie, AK | 1 |
| Beresford, JA; Grigg, A; Matthews, JP; Sasadeusz, J; Steer, CB; Szer, J | 1 |
| Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V | 1 |
1 trial(s) available for valine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Age of Onset; Aged; Analysis of Variance; Antiviral Agents; Bone Marrow Transplantation; Chickenpox; Dose-Response Relationship, Drug; Enzyme Activation; Famciclovir; Female; Ganciclovir; Graft vs Host Disease; Herpes Zoster; Herpesvirus 3, Human; Humans; Incidence; Male; Middle Aged; Prodrugs; Retrospective Studies; Risk Factors; Skin Diseases; Transplantation, Homologous; Valacyclovir; Valine | 2000 |
7 other study(ies) available for valine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Gene Expression; Graft vs Host Disease; Histocompatibility Testing; Humans; Imidazoles; Lacrimal Apparatus; Liver; Lung; Male; Mice; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2013 |
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases.
Topics: Animals; Autoimmune Diseases; Cell Line; Databases, Chemical; Dogs; Female; Graft vs Host Disease; Haplorhini; Heterocyclic Compounds, 2-Ring; Humans; Janus Kinase 2; Janus Kinase 3; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Microsomes, Liver; Models, Molecular; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Valine | 2015 |
A unique presentation of acute liver failure from herpes simplex virus hepatitis.
Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Liver; Liver Failure, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Patient Comfort; Polymerase Chain Reaction; Simplexvirus; Transaminases; Transplantation, Homologous; Valacyclovir; Valine | 2016 |
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Resistance, Viral; Drugs, Investigational; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Investigational New Drug Application; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Organophosphonates; Transplantation, Homologous; Valacyclovir; Valine | 2016 |
Epstein-Barr virus-associated oral papulosis in graft-versus-host disease.
Topics: Acyclovir; Antiviral Agents; Epstein-Barr Virus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Tongue Diseases; Treatment Outcome; Valacyclovir; Valine | 2010 |
Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Janus Kinase 2; Leukemia; Male; Middle Aged; Mutation; Phenylalanine; Recurrence; Thrombocythemia, Essential; Treatment Failure; Valine | 2007 |
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation | 2001 |